Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model. [PDF]
Front Immunol, 2022 Jiang W +8 more
europepmc +1 more source
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington. [PDF]
Vaccine, 2021 Rane MS, Rohani P, Halloran ME.
europepmc +1 more source
More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands. [PDF]
Lancet Reg Health Eur, 2021 Versteegen P +6 more
europepmc +1 more source
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines
npj VaccinesDespite robust antibody responses, immunity induced by acellular pertussis vaccine (DTaP) wanes over time and risk of pertussis seems to be lower in children who receive whole-cell vaccine (DTP) as their first dose.
C. Buddy Creech +15 more
doaj +1 more source
Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule? [PDF]
Ther Adv Vaccines Immunother, 2021 Esteghamati A +4 more
europepmc +1 more source
Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015. [PDF]
J Pediatric Infect Dis Soc, 2021 europepmc +1 more source
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. [PDF]
Trials, 2022 Totterdell JA +6 more
europepmc +1 more source
Effectiveness and impact of the 2-component acellular pertussis vaccine as a preschool booster in Finland - A register-based study. [PDF]
PLOS Glob Public HealthHalme JA +7 more
europepmc +1 more source